Tag: Neonatal Abstinence Syndrome

DES PLAINES, Ill., Oct. 1, 2019 (SEND2PRESS NEWSWIRE) -- Over the last few decades, United States Drug Testing Laboratories, Inc. (USDTL), has been quietly making a huge impact on the lives of some of the most vulnerable Neonatal Intensive Care Unit (NICU) patients, newborns exposed to substances of abuse during gestation. Today USDTL announced that they are the first laboratory in the world to commercially offer newborn fentanyl testing in both meconium and umbilical cord tissue specimens.